shares of seqll inc sql more than doubled on heavy volume ahead of friday’s open in the wake of the genetic sequencing company’s announcement earlier in the week about an product development agreement with the federal bureau of investigation the stock skyrocketed 1286 on volume of 161 million shares premarket enough to make it the biggest gainer and most active stock listed on major us exchanges the stock had soared 1855 on volume of 1061 million shares on tuesday after the company announced a twoyear cooperative research and development agreement crada with the fbi to evaluate the forensic capabilities of direct rna sequencing using seqll’s molecule sequencing platform after that rally the stock had tumbled 455 over the past two days the stock’s early gain on friday would put it on track for the highest close in 13 months still the stock has dropped 455 over the past 12 months while the ishares biotechnology exchangetraded fund ibb has edged up 05 and the sp 500 spx has lost 94